1593542-96-1 Usage
Description
(3R,4R)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one is a complex organic compound with a unique molecular structure. It is characterized by its azetidinone ring and multiple phenyl groups, which contribute to its potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(3R,4R)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one is used as a structural analog for the development of new drugs, specifically in the area of antihyperlipoproteinemic and cholesterol absorption inhibition. Its structural similarity to Ezetimibe allows for the exploration of its potential as a therapeutic agent for managing hyperlipidemia and related conditions.
Used in Chemical Research:
In the field of chemical research, (3R,4R)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one can be utilized as a starting material or intermediate for the synthesis of other complex organic molecules. Its unique structure may provide new insights into the design and synthesis of novel compounds with potential applications in various industries.
Used in Material Science:
The compound's structural features may also make it a candidate for use in material science, where it could be explored for its potential properties in creating new materials with specific characteristics, such as improved mechanical strength, thermal stability, or chemical resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 1593542-96-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,9,3,5,4 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1593542-96:
(9*1)+(8*5)+(7*9)+(6*3)+(5*5)+(4*4)+(3*2)+(2*9)+(1*6)=201
201 % 10 = 1
So 1593542-96-1 is a valid CAS Registry Number.
1593542-96-1Relevant articles and documents
First synthesis and characterization of key stereoisomers related to Ezetimibe
Ren, Yun,Duan, Yan-Jun,Li, Ren-Jun,Deng, Yong,Hai, Li,Wu, Yong
, p. 1157 - 1160 (2014/08/18)
During the laboratory optimization and the late phase manufacturing studies of the cholesterol absorption inhibitor Ezetimibe 1, the formation of several stereoisomers was observed. To study the complete stereoisomer profile of Ezetimibe 1, we have synthesized and completely characterized several key stereoisomers of Ezetimibe 1 for the first time. This study will provide an access to the reference standard of these stereoisomers and may have some implications in the development of new medicines.